(Q45997022)

18 December 2017

title

Endothelial-selectin ligands sialyl Lewis(x) and sialyl Lewis(a) are differentiation antigens immunogenic in human melanoma. (English)

1 reference

18 December 2017

0 references

6

Morton DL

1 reference

18 December 2017

author name string

Ravindranath MH

1

1 reference

18 December 2017

Amiri AA

2

1 reference

18 December 2017

Bauer PM

3

1 reference

18 December 2017

Kelley MC

4

1 reference

18 December 2017

Essner R

5

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

18 December 2017

published in

Cancer

1 reference

18 December 2017

volume

79

1 reference

18 December 2017

issue

9

1 reference

18 December 2017

page(s)

1686-1697

1 reference

18 December 2017

ELAM-1 Mediates Cell Adhesion by Recognition of a Carbohydrate Ligand, Sialyl-Le x

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

Recognition by Elam-1 of the Sialyl-Le x Determinant on Myeloid and Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

A ligand binding assay for E-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

Sialyl-Lewis(x) and related carbohydrate antigens in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

21 January 2018

Is that what you mean?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

On the structure of polymeric IgM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1686%3A%3AAID-CNCR8%3E3.0.CO%3B2-A

10.1002/(SICI)1097-0142(19970501)79:9<1686::AID-CNCR8>3.0.CO;2-A

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

9128983

1 reference

18 December 2017